GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Frontier Biotechnologies Inc (SHSE:688221) » Definitions » Issuance of Debt

Frontier Biotechnologies (SHSE:688221) Issuance of Debt : ¥416.7 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Frontier Biotechnologies Issuance of Debt?

Frontier Biotechnologies's Issuance of Debt for the three months ended in Sep. 2024 was ¥42.7 Mil.

Frontier Biotechnologies's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was ¥416.7 Mil.

Frontier Biotechnologies Issuance of Debt Historical Data

The historical data trend for Frontier Biotechnologies's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Frontier Biotechnologies Issuance of Debt Chart

Frontier Biotechnologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Issuance of Debt
Get a 7-Day Free Trial 41.36 14.99 279.69 202.57 312.80

Frontier Biotechnologies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.20 92.12 98.91 183.02 42.68

Frontier Biotechnologies Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥416.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frontier Biotechnologies Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Frontier Biotechnologies's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Frontier Biotechnologies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Frontier Biotechnologies Inc (SHSE:688221) » Definitions » Issuance of Debt
Comparable Companies
SZSE:300110 SHSE:688799 SHSE:600530 SHSE:603520 SZSE:002082 SZSE:002644 SZSE:002793 SHSE:603998 SZSE:301089 SZSE:300158 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 5 Gande Road, 7th Floor, Science Park, Jiangning District, Jiangsu Province, Nanjing, CHN, 211122
Website
http://www.frontierbiotech.com
Frontier Biotechnologies Inc is an innovative biomedical company. It is engaged in the production and sales of innovative drugs for major unmet clinical needs. The company focuses on the research and development of new drugs in the field of long-acting peptides and differentiated product development strategies for unmet clinical and patient needs.

Frontier Biotechnologies Headlines

No Headlines